Recent Advances in Cyclic Peptide-Based Therapeutic Strategies for Renal Cell Carcinoma: A Focused Review
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s638461 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Liming Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Peptides, Cyclic, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.
- Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.
ORCID-Profile: Guangzhen Wu
Zitieren
APA
Sun, L., Li, X., Liu, Y., & Wu, G. (2026). Recent Advances in Cyclic Peptide-Based Therapeutic Strategies for Renal Cell Carcinoma: A Focused Review. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s638461
Vancouver
Sun L, Li X, Liu Y, Wu G. Recent Advances in Cyclic Peptide-Based Therapeutic Strategies for Renal Cell Carcinoma: A Focused Review. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s638461
BibTeX
@article{Sun2026,
author = {Sun, Liming and Li, Xiaoting and Liu, Yan and Wu, Guangzhen},
title = {Recent Advances in Cyclic Peptide-Based Therapeutic Strategies for Renal Cell Carcinoma: A Focused Review},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s638461}
}
EUVIMED